The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
Open accessAbstract
Significance: mAbs are increasingly being used for treatment of chronic diseases wherein the subcutaneous delivery route is preferred to enable self-administration and at-home use. To deliver high doses (several hundred milligrams) through a small volume (∼1 mL) into the subcutaneous space, mAb solutions need to have low viscosity. Concomitantly, acceptable chemical stability is required for adequate shelf life, and normal in vivo clearance is needed for less frequent dosing. We propose in silico tools that provide rapid assessment of atypical behavior of mAbs (high viscosity, chemical degradation, and fast plasma clearance), which are simply predicted from sequence and/or structure-derived parameters. Such analysis will greatly improve the probability of success to move mAb-based therapeutics efficiently into clinical development and ultimately benefit patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Analysis of membrane and surface protein sequences with the hydrophobic moment plot
Eisenberg, D., Schwarz, E., Komaromy, M., & Wall, R. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90309-7 · Cited by 2,284
Eisenhaber, F., Lijnzaad, P., Argos, P., Sander, C., & Scharf, M. (1995) · Journal of Computational Chemistry · doi:10.1002/jcc.540160303 · Cited by 1,055
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Design of therapeutic proteins with enhanced stability
Chennamsetty, N., Voynov, V., Kayser, V., Helk, B., & Trout, B. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904191106 · Cited by 598
Liu, J., Nguyen, M. D. H., Andya, J. D., & Shire, S. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20347 · Cited by 436
Wu, H., Pfarr, D. S., Johnson, S., Brewah, Y. A., Woods, R. M., Patel, N. K., White, W. I., Young, J. F., & Kiener, P. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.024 · Cited by 373
Connolly, B. D., Petry, C., Yadav, S., Demeule, B., Ciaccio, N., Moore, J. M. R., Shire, S. J., & Gokarn, Y. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.047 · Cited by 340
Kanai, S., Liu, J., Patapoff, T. W., & Shire, S. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21322 · Cited by 304
Self-citationReduced elimination of IgG antibodies by engineering the variable region
Igawa, T., Tsunoda, H., Tachibana, T., Maeda, A., Mimoto, F., Moriyama, C., Nanami, M., Sekimori, Y., Nabuchi, Y., Aso, Y., et al. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq009 · Cited by 265 · cited 1×
“A few studies have shown such differences to be correlated to pI or specific mutations in the sequence (15, 16); however, no clear trend is reported.”
BackgroundSpecific interactions in high concentration antibody solutions resulting in high viscosity
Yadav, S., Liu, J., Shire, S. J., & Kalonia, D. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21898 · Cited by 252
A strategy for risk mitigation of antibodies with fast clearance
Hötzel, I., Theil, F.-P., Bernstein, L. J., Prabhu, S., Deng, R., Quintana, L., Lutman, J., Sibia, R., Chan, P., Bumbaca, D., et al. (2012) · mAbs · doi:10.4161/mabs.22189 · Cited by 245
Self-citationJi, J. A., Zhang, B., Cheng, W., & Wang, Y. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21746 · Cited by 215
Self-citationSydow, J. F., Lipsmeier, F., Larraillet, V., Hilger, M., Mautz, B., Mølhøj, M., Kuentzer, J., Klostermann, S., Schoch, J., Voelger, H. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100736 · Cited by 161
Zheng, Y., Tesar, D. B., Benincosa, L., Birnböck, H., Boswell, C. A., Bumbaca, D., Cowan, K. J., Danilenko, D. M., Daugherty, A. L., Fielder, P. J., et al. (2012) · mAbs · doi:10.4161/mabs.4.2.19387 · Cited by 149
Full correlation analysis of conformational protein dynamics
Lange, O. F., & Grubmüller, H. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21618 · Cited by 140
Radkiewicz, J. L., Zipse, H., Clarke, S. G., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0026814 · Cited by 139
Li, L., Kumar, S., Buck, P. M., Burns, C., Lavoie, J., Singh, S. K., Warne, N. W., Nichols, P., Luksha, N., & Boardman, D. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1409-0 · Cited by 132
Wakankar, A. A., Borchardt, R. T., Eigenbrot, C. W., et al. (2007) · Biochemistry · doi:10.1021/bi061500t · Cited by 128
Yadav, S., Sreedhara, A., Kanai, S., Liu, J., Lien, S., Lowman, H. B., Kalonia, D. S., & Shire, S. J. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0410-0 · Cited by 122
Hydrophobic salts markedly diminish viscosity of concentrated protein solutions
Du, W., & Klibanov, A. M. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22983 · Cited by 108
Computational Methods to Predict Therapeutic Protein Aggregation
Buck, P. M., Kumar, S., Wang, X., Agrawal, N. J., Trout, B. L., & Singh, S. K. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-921-1_26 · Cited by 61
Probing antibody internal dynamics with fluorescence anisotropy and molecular dynamics simulations
Kortkhonjia, E., Brandman, R., Zhou, J. Z., Voelz, V. A., Chorny, I., Kabakoff, B., Patapoff, T. W., Dill, K. A., & Swartz, T. E. (2013) · mAbs · doi:10.4161/mabs.23651 · Cited by 35
Self-citationIsomerization of Asp–Asp Motif in Model Peptides and a Monoclonal Antibody Fab Fragment
Yi, L., Adeniji, N., Gikanga, B., Zhang, J., Wang, Y. J., Chih, H., & Sharma, V. K. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23423 · Cited by 24
Self-citationEisenstein, M. S. (2011) · Nature Biotechnology · doi:10.1038/nbt.1768 · Cited by 15
Cited by
Biophysical properties of the clinical-stage antibody landscape
Jain, T., Sun, T., Durand, S., Hall, A., Houston, N. R., Nett, J. H., Sharkey, B., Bobrowicz, B., Caffry, I., Yu, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616408114 · Cited by 629
Five computational developability guidelines for therapeutic antibody profiling
Raybould, M. I. J., Marks, C., Krawczyk, K., Taddese, B., Nowak, J., Lewis, A. P., Bujotzek, A., Shi, J., & Deane, C. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810576116 · Cited by 357
Mason, D. M., Friedensohn, S., Weber, C. R., Jordi, C., Wagner, B., Meng, S. M., Ehling, R. A., Bonati, L., Dahinden, J., Gainza, P., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00699-9 · Cited by 308
Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development
Ovacik, M., & Lin, K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12567 · Cited by 299
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Metadata
- Authors
- Sharma, V. K., Patapoff, T. W., Kabakoff, B., Pai, S., Hilario, E., Zhang, B., Li, C., Borisov, O., Kelley, R. F., Chorny, I., Zhou, J. Z., Dill, K. A., & Swartz, T. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-12-15
- Volume
- 111
- Issue
- 52
- Pages
- 18601-18606
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1971021060
- Cited by
- 254
- References
- 29
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.